Related Experiment Video
Updated: May 8, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Dopamine D2 receptors regulate collateral inhibition between striatal medium spiny neurons
Rupa R Lalchandani1, Marie-Sophie van der Goes, John G Partridge
1Graduate Program in Physiology and Biophysics, Department of Pharmacology & Physiology, Georgetown University, Washington, DC 20007, USA. rrl23@georgetown.edu
Chronic D2 receptor stimulation strengthens GABAergic medium spiny neuron (MSN) collaterals via presynaptic and postsynaptic changes. This impacts striatal function and may offer insights into neurological disorders like Parkinson's disease.
Area of Science:
- Neuroscience
- Cellular Biology
- Synaptic Plasticity
Background:
- Medium spiny neurons (MSNs) are principal striatal neurons utilizing GABAergic collateral synapses.
- D1-class and D2-class MSNs differ in dopamine receptor expression, with D2 MSNs linked to pathology.
- The precise impact of D2 receptor (D2R) activation on MSN collaterals is not fully understood.
Purpose of the Study:
- To investigate how chronic D2R stimulation alters MSN collateral synapses.
- To elucidate the presynaptic and postsynaptic mechanisms involved in D2R-mediated regulation of MSN collaterals.
Main Methods:
- Utilized in vitro corticostriatal cultures from mice with distinct MSN subtypes.
- Employed chronic stimulation with quinpirole, a D2/3 receptor agonist.
- Assessed collateral formation, synaptic strength, and receptor changes using patch-clamp recordings and immunofluorescence.
Main Results:
- Chronic D2R activation increased collateral formation and synaptic strength onto D2R-containing MSNs.
- Observed enhanced postsynaptic sensitivity to GABA and increased gephyrin puncta density.
- Detected increased presynaptic GABA release sites, indicated by higher sIPSC/mIPSC frequencies and VGAT puncta.
Conclusions:
- D2R activation significantly modifies MSN collaterals through coordinated presynaptic and postsynaptic alterations.
- These findings highlight a potential mechanism underlying D2 MSN dysfunction in neurological disorders.
- The study provides a basis for understanding and potentially treating pathological changes in D2 MSNs.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action
Diencephalon: Thalamus and Information Relay
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Neural Regulation
Drugs Affecting Neurotransmitter Release or Uptake

